How AI is speeding up COVID-19 diagnosis

Healthcare organizations are still dealing with COVID-19 patients, and testing applications are ramping up all over the U.S. At the same time, AI is stepping in to help speed up the diagnosis of COVID-19 and expedite how much time healthcare professionals spend determining COVID-19 pneumonia and non-COVID-19 cases.

The AI tool is developed by researchers from Simon Fraser University and Providence Health Care and is currently in the validation phase at St. Paul’s Hospital in Vancouver, Canada. It works by analyzing a patient’s chest x-ray image, using bio-image detection to determine if a positive pneumonia case is consistent with COVID-19. Researchers used x-ray images of COVID-19 and non-COVID-19 to refine the machine learning system and find the unique characteristics of the virus.

It is not a standalone diagnosis tool, but it can help doctors and professionals quickly assist confirmation of their suspicions about a patient’s diagnosis. The tool can be used with others, such as CT scans.

“Instead of doctors checking each X-ray image individually, this system is trained to use algorithms and data to identify it for them,” Yagiz Aksoy, assistant professor in the School of Computing Science’s GrUVi Lab, said in a statement.

The tool can also detect and classify other types of chest x-ray pneumonia images, including bacterial, fungal and other viral cases.

Upon approval, the organizations plan to make the tool available for free, with support from the U.N. The United Nations Global Platform already holds a beta version of the tool and “is whitelisted in the [Amazon Web Services] Machine Learning Marketplace,” according to a press release.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”